Texts by Liad Hollender, Science writer & editor of the CCU Communication, Outreach and Events team.

Illustrations & Motion Graphics by Diogo Matias, designer of the CCU Communication, Outreach and Events team.

Editing by Hedi Young, Digital Content & Social Media Editor of the CCU Communication, Outreach and Events team.

Henrique Veiga-Fernandes, Immunologist, Principal Investigator and one of the Directors of Champalimaud Research; and Ana Paula Pêgo, group leader at i3S - Institute for Research and Innovation in Health, now join an elite group of world-renowned scientists on the Science Review Editors Council.

On the Honourable Mentions, the jury president, anatomopathology doctor and researcher Manuel Sobrinho Simões, referenced that “the jury distinguished (…) two works that show medical research's relevance and urgency; on the one hand cancer and new therapies that mark the research that is being done in this field and, on the other, the pandemic that dominated the year 2020.”

In many species, including humans and mice, the fluctuating levels of the hormones progesterone and estrogen determine whether the female is fertile or not. And in the case of mice, whether she’s sexually receptive or not. 

The change in receptivity is striking. Female mice shift from accepting sexual partners to aggressively rejecting them across a cycle of six short days. How can the female reproductive hormones bring about such a radical behavioural change?

Following the highly successful 2019 edition, attended by around 400 delegates from over 30 countries, the 2021 meeting aims to promote better understanding and application of AI and ML in cancer imaging; and provide a multidisciplinary forum for radiologists, technicians/radiographers, scientists and industrial partners to discuss and interact.

One year after the COVID-19 pandemic started in Portugal, the campaign "Conversas com Cientistas - Décadas de Ciência para Dias de Vacinas" kicks off.

Radical surgical removal of the prostate is the most frequent treatment for prostate cancer when the tumour is localised (meaning it has not spread outside the prostate). 

This workshop brings together agency, regulator, industry and primary researcher communities in biomedical sciences to talk freely about methods and models and explore common ground.

This is a Champalimaud Foundation workshop co-organised with CONGENTO and QuantOCancer projects, the Joint Research Centre (JRC) and FRESCI.

During this event we will:

For the first time, this Ar Event was available solely online, but that didn’t stop viewers from interacting on all of the available platforms - Zoom, Facebook Live and YouTube - with more than 200 questions shared with our panel of experts.  According to Dr. Bill Richards (who you’ll get to know later!), we are “Moving into new terrain… and we welcome you to join us!”

This Gulbenkian Knowledge Academy is looking for young people ready to embark on an intergalactic journey into the future of neuroscience!

In this edition, candidates will be able to choose one of two possible trips - Long Flight (lasting about 4 weeks) or Short Flight (lasting around 2 weeks). For the first, 16 Neurocadets will be recruited and for the second, 8 Chimeras!